FosA3 emerging in clinical carbapenemase-producing C. freundii
Fosfomycin (FOS) is an effective antibiotic against multidrug-resistant Enterobacterales, but its effectiveness is reducing. Little is known on the current prevalence of FosA enzymes in low-risk pathogens, such as Citrobacter freundii. The aim of the study was the molecular characterization of a car...
Gardado en:
| Principais autores: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Frontiers Media S.A.
2024-08-01
|
| Series: | Frontiers in Cellular and Infection Microbiology |
| Assuntos: | |
| Acceso en liña: | https://www.frontiersin.org/articles/10.3389/fcimb.2024.1447933/full |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|